Assessing Kenya’s Readiness for Vaccine and Biotherapeutics Manufacturing by BioVax: Challenges, Strategies, and Stakeholder Insights
World Journal of Vaccines · 2026 · 16 (03) · 45-75
DOI: 10.4236/wjv.2026.163003 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Vaccines, 2026. Verfasst von Abook Brian und 3 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Brian, A., Wanjala, C., Odhiambo, J., & Muteru, S. (2026). Assessing Kenya’s Readiness for Vaccine and Biotherapeutics Manufacturing by BioVax: Challenges, Strategies, and Stakeholder Insights. World Journal of Vaccines, 16(03), 45-75. https://doi.org/10.4236/wjv.2026.163003
Vancouver
Brian A, Wanjala C, Odhiambo J, Muteru S. Assessing Kenya’s Readiness for Vaccine and Biotherapeutics Manufacturing by BioVax: Challenges, Strategies, and Stakeholder Insights. World Journal of Vaccines. 2026;16(03):45-75. doi:10.4236/wjv.2026.163003
BibTeX
@article{Brian2026,
author = {Brian, Abook and Wanjala, Cecilia and Odhiambo, Joāb and Muteru, Serah},
title = {Assessing Kenya’s Readiness for Vaccine and Biotherapeutics Manufacturing by BioVax: Challenges, Strategies, and Stakeholder Insights},
journal = {World Journal of Vaccines},
year = {2026},
volume = {16},
number = {03},
pages = {45--75},
doi = {10.4236/wjv.2026.163003}
}
EUVIMED